Chinese National Convicted of Conspiracy to Steal Cancer Drug Trade Secrets to Benefit China-Backed Company

Chinese National Convicted of Conspiracy to Steal Cancer Drug Trade Secrets to Benefit China-Backed Company
A GSK employee is at work at the factory of British pharmaceutical company GlaxoSmithKline (GSK) in Wavre, Belguim, on Feb. 8, 2021. (Photo by Kenzo TRIBOUILLARD / AFP) Photo by KENZO TRIBOUILLARD/AFP via Getty Images
Andrew Thornebrooke
Andrew Thornebrooke
National Security Correspondent
|Updated:
0:00

A Swiss-based Chinese scientist was convicted for his role in a family conspiracy to steal trade secrets related to cancer drugs, according to the Department of Justice (DOJ).

Xue Gongda, 52, a permanent resident of Switzerland with Chinese citizenship, was convicted in connection with a $10 billion scheme to steal cancer medications from his employer and rebrand them under his own biomedical company, U.S. Attorney Jennifer Williams announced on May 2.
Andrew Thornebrooke
Andrew Thornebrooke
National Security Correspondent
Andrew Thornebrooke is a national security correspondent for The Epoch Times covering China-related issues with a focus on defense, military affairs, and national security. He holds a master's in military history from Norwich University.
twitter
Related Topics